These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18201395)

  • 21. [Papillomavirus vaccines: dream or revolution?].
    Denis F
    Gynecol Obstet Fertil; 2006; 34(7-8):569-70. PubMed ID: 16797209
    [No Abstract]   [Full Text] [Related]  

  • 22. The potential of human papillomavirus vaccines.
    Steinbrook R
    N Engl J Med; 2006 Mar; 354(11):1109-12. PubMed ID: 16540608
    [No Abstract]   [Full Text] [Related]  

  • 23. Human papillomavirus vaccine, teen sex and politics.
    Olatunbosun O
    J Fam Plann Reprod Health Care; 2006 Apr; 32(2):74. PubMed ID: 16824294
    [No Abstract]   [Full Text] [Related]  

  • 24. HPV and cervical cancer in the 2007 report.
    WHO/ICO Information Centre on HPV and Cervical Cancer
    Vaccine; 2007 Nov; 25 Suppl 3():C1-230. PubMed ID: 18068032
    [No Abstract]   [Full Text] [Related]  

  • 25. Human papillomavirus vaccines: what does the future hold for preventing cervical cancer in resource-poor settings through immunization programs?
    Jacob M; Bradley J; Barone MA
    Sex Transm Dis; 2005 Oct; 32(10):635-40. PubMed ID: 16205306
    [No Abstract]   [Full Text] [Related]  

  • 26. Planning for the HPV vaccine and its impact on cervical cancer prevention.
    Bailey J; Cymet TC
    Compr Ther; 2006; 32(2):102-5. PubMed ID: 16845153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus vaccination: expected impacts and unresolved issues.
    Dempsey AF; Freed GL
    J Pediatr; 2008 Mar; 152(3):305-9. PubMed ID: 18280831
    [No Abstract]   [Full Text] [Related]  

  • 28. [Biology of the papillomavirus infections: V. Vaccine developments].
    Seilles E; Riethmuller D; Mougin C
    Ann Biol Clin (Paris); 1999; 57(5):517-24. PubMed ID: 10518053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Papillomavirus-like particle vaccines for cervical cancer.
    Schiller JT
    Mol Med Today; 1999 May; 5(5):209-15. PubMed ID: 10322313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Red-algae derivative could be useful adjunct to HPV vaccine.
    Bagchi S
    Lancet Oncol; 2006 Aug; 7(8):623. PubMed ID: 16903009
    [No Abstract]   [Full Text] [Related]  

  • 31. Where to begin human papillomavirus vaccination?
    Bonney LE; Lally M; Williams DR; Stein M; Flanigan T
    Lancet Infect Dis; 2006 Jul; 6(7):389-90. PubMed ID: 16790378
    [No Abstract]   [Full Text] [Related]  

  • 32. Routine vaccination against human papillomavirus.
    Lancet Infect Dis; 2008 Mar; 8(3):141. PubMed ID: 18291330
    [No Abstract]   [Full Text] [Related]  

  • 33. Vaccination against human papillomaviruses shows great promise.
    Lehtinen M; Paavonen J
    Lancet; 2004 Nov 13-19; 364(9447):1731-2. PubMed ID: 15541429
    [No Abstract]   [Full Text] [Related]  

  • 34. [Vaccination against human papillomavirus infections].
    Prétet JL; Alvarez E; Monnier-Benoit S; Touzé A
    Rev Prat; 2006 Nov; 56(17):1914-8. PubMed ID: 17243390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus vaccines.
    Stanley MA
    Rev Med Virol; 2006; 16(3):139-49. PubMed ID: 16710836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus, cervical cancer prevention, and more.
    Lowy D
    Vaccine; 2008 Aug; 26 Suppl 10():iii-iv. PubMed ID: 18847562
    [No Abstract]   [Full Text] [Related]  

  • 37. HPV genotypes: implications for worldwide cervical cancer screening and vaccination.
    Wheeler CM
    Lancet Oncol; 2010 Nov; 11(11):1013-4. PubMed ID: 20952255
    [No Abstract]   [Full Text] [Related]  

  • 38. Technology evaluation: HPV vaccine (quadrivalent), Aventis Pasteur MSD/CSL.
    Reinis M
    Curr Opin Mol Ther; 2004 Apr; 6(2):206-11. PubMed ID: 15195933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
    Goldstone SE; Vuocolo S
    Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias.
    Paavonen J
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S3-9. PubMed ID: 18162244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.